Journal Articles ChemistryOpen Year : 2020

Structure‐Based Design and Synthesis of Piperidinol‐Containing Molecules as New Mycobacterium abscessus Inhibitors

Abstract

Non-tuberculous mycobacterium (NTM) infections, such as those caused by Mycobacterium abscessus, are increasing globally. Due to their intrinsic drug resistance, M. abscessus pulmonary infections are often difficult to cure using standard chemotherapy. We previously demonstrated that a piperidinol derivative, named PIPD1, is an efficient molecule both against M. abscessus and Mycobacterium tuberculosis, the agent of tuberculosis, by targeting the mycolic acid transporter MmpL3. These results prompted us to design and synthesize a series of piperidinol derivatives and to determine the biological activity against M. abscessus. Structure-activity relationship (SAR) studies pointed toward specific sites on the scaffold that can tolerate slight modifications. Overall, these results identified FMD-88 as a new promising active analogue against M. abscessus. Also, we determined the pharmacokinetics properties of PIPD1 and showed that intraperitoneal administration of this compound resulted in promising serum concentration and an elimination half-life of 3.2 hours.

Fichier principal
Vignette du fichier
open.202000042.pdf (3.07 Mo) Télécharger le fichier
Origin Publisher files allowed on an open archive
Licence
Loading...

Dates and versions

hal-02988322 , version 1 (05-11-2020)

Licence

Identifiers

Cite

Jérôme Ruyck, Christian Dupont, Elodie Lamy, Vincent Le Moigne, Christophe Biot, et al.. Structure‐Based Design and Synthesis of Piperidinol‐Containing Molecules as New Mycobacterium abscessus Inhibitors. ChemistryOpen, 2020, 9 (3), pp.351-365. ⟨10.1002/open.202000042⟩. ⟨hal-02988322⟩
176 View
266 Download

Altmetric

Share

  • More